27 related articles for article (PubMed ID: 27693669)
1. Association of IL-1β gene polymorphisms rs1143627, rs1799916, and rs16944 with altered risk of triple-negative breast cancer.
Sghaier I; Sheridan JM; Daldoul A; El-Ghali RM; Al-Awadi AM; Habel AF; Aimagambetova G; Almawi WY
Cytokine; 2024 Aug; 180():156659. PubMed ID: 38781872
[TBL] [Abstract][Full Text] [Related]
2. Impact of interleukin-1β single nucleotide polymorphisms and depressive symptoms in individuals with chronic viral hepatitis.
Huang HY; Yu RL; Tsai WF; Chuang WL; Huang JF; Dai CY; Tan CH
Kaohsiung J Med Sci; 2024 Jan; 40(1):94-104. PubMed ID: 37937732
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory profile of lower risk myelodysplastic syndromes.
Topping J; Taylor A; Nadat F; Crouch S; Ibbotson A; Čermák J; Symeonidis A; Tatic A; Langemeijer S; Hellström-Lindberg E; Culligan D; Garelius HG; Ashcroft J; Nga E; Parker J; Kolade S; McDermott MF; De Witte T; Bowen D; Smith A; Cargo C; Savic S;
Br J Haematol; 2024 May; ():. PubMed ID: 38772913
[TBL] [Abstract][Full Text] [Related]
4. Impact of IL-6 and IL-1β Gene Variants on Non-small-cell Lung Cancer Risk in Egyptian Patients.
Metwally YF; Elsaid AM; Elsadda RR; Refaat S; Zahran RF
Biochem Genet; 2023 Dec; ():. PubMed ID: 38103126
[TBL] [Abstract][Full Text] [Related]
5. The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype.
Basiorka AA; McGraw KL; Eksioglu EA; Chen X; Johnson J; Zhang L; Zhang Q; Irvine BA; Cluzeau T; Sallman DA; Padron E; Komrokji R; Sokol L; Coll RC; Robertson AA; Cooper MA; Cleveland JL; O'Neill LA; Wei S; List AF
Blood; 2016 Dec; 128(25):2960-2975. PubMed ID: 27737891
[TBL] [Abstract][Full Text] [Related]
6. Phase 2 study of low-dose clofarabine plus cytarabine for patients with higher-risk myelodysplastic syndrome who have relapsed or are refractory to hypomethylating agents.
Jabbour E; Faderl S; Sasaki K; Kadia T; Daver N; Pemmaraju N; Patel K; Khoury JD; Bueso-Ramos C; Bohannan Z; Ravandi F; Borthakur G; Verstovsek S; Miller D; Maduike R; Hosing C; Kantarjian HM; Garcia-Manero G
Cancer; 2017 Feb; 123(4):629-637. PubMed ID: 27741352
[TBL] [Abstract][Full Text] [Related]
7. Deregulation of New Cell Death Mechanisms in Leukemia.
Favale G; Donnarumma F; Capone V; Della Torre L; Beato A; Carannante D; Verrilli G; Nawaz A; Grimaldi F; De Simone MC; Del Gaudio N; Megchelenbrink WL; Caraglia M; Benedetti R; Altucci L; Carafa V
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730609
[TBL] [Abstract][Full Text] [Related]
8. Inflammasomes-New Contributors to Blood Diseases.
Tomasik J; Basak GW
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897704
[TBL] [Abstract][Full Text] [Related]
9. NLRP3 Inflammasome Promotes the Progression of Acute Myeloid Leukemia
Zhong C; Wang R; Hua M; Zhang C; Han F; Xu M; Yang X; Li G; Hu X; Sun T; Ji C; Ma D
Front Immunol; 2021; 12():661939. PubMed ID: 34211462
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms of inflammasome genes associated with pediatric acute lymphoblastic leukemia and clinical prognosis in the Brazilian Amazon.
Alves FS; Xabregas LA; Kerr MWA; Souza GL; Pereira DS; Magalhães-Gama F; Santiago MRR; Garcia NP; Tarragô AM; Ogusku MM; Sadahiro A; Malheiro A; Costa AG
Sci Rep; 2021 May; 11(1):9869. PubMed ID: 33972620
[TBL] [Abstract][Full Text] [Related]
11. The NLRP3 Inflammasome and Its Role in the Pathogenicity of Leukemia.
Urwanisch L; Luciano M; Horejs-Hoeck J
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525345
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms of IL-18 rs1946518 and IL-1β rs16944 are associated with prognosis and survival of acute myeloid leukemia.
Wang H; Hua M; Wang S; Yu J; Chen C; Zhao X; Zhang C; Zhong C; Wang R; He N; Hou M; Ma D
Inflamm Res; 2017 Mar; 66(3):249-258. PubMed ID: 27928589
[TBL] [Abstract][Full Text] [Related]
13. The
Fu LY; Qiu X; Deng QL; Huang P; Pi L; Xu Y; Che D; Zhou H; Lu Z; Tan Y; Jiang Z; Zhang L; Liu T; Gu X
J Immunol Res; 2019; 2019():4730507. PubMed ID: 31093510
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of IL-10 affect the severity and prognosis of myelodysplastic syndrome.
Kasamatsu T; Saitoh T; Minato Y; Shimizu H; Yokohama A; Tsukamoto N; Handa H; Sakura T; Murakami H
Eur J Haematol; 2016 Mar; 96(3):245-51. PubMed ID: 25941112
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1 promoter region polymorphism role in rheumatoid arthritis: a meta-analysis of IL-1B-511A/G variant reveals association with rheumatoid arthritis.
Harrison P; Pointon JJ; Chapman K; Roddam A; Wordsworth BP
Rheumatology (Oxford); 2008 Dec; 47(12):1768-70. PubMed ID: 18838388
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms of Interlukin-1β rs16944 confer susceptibility to myelodysplastic syndromes.
Yin C; He N; Li P; Zhang C; Yu J; Hua M; Ji C; Ma D
Life Sci; 2016 Nov; 165():109-112. PubMed ID: 27693669
[TBL] [Abstract][Full Text] [Related]
17. The genetic polymorphism and expression profiles of NLRP3 inflammasome in patients with chronic myeloid leukemia.
Zhang A; Yu J; Yan S; Zhao X; Chen C; Zhou Y; Zhao X; Hua M; Wang R; Zhang C; Zhong C; He N; Ji C; Ma D
Hum Immunol; 2018 Jan; 79(1):57-62. PubMed ID: 29097263
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
